drugset / Trial / NCT06865079

53-Week Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 With Mild to Severe Tibio-Femoral Osteoarthritis of the Knee

NCT06865079 ↗

Phase 2 Active not recruiting 270 enrolled OrthoTrophix, Inc
RandomizedParallel-groupQuadruple-blindTreatment

Summary

53-Week Study Evaluating the Safety and Efficacy of Intra-articular (IA) Injections of TPX-100 vs Placebo in Subjects with Mild to Severe Tibio-Femoral Osteoarthritis of the Knee

Timeline

Start
2025-05-09
Primary completion
2027-03-25
Completion
2027-04-15

Drugs

EvaluationDrugModalityDoseRoute
Subject TPX-100 Peptide 200 mg Other

Indications